ProCE Banner Activity

Abstract: MOUNTAINEER-03: Phase 3 study of tucatinib, trastuzumab, and mFOLFOX6 as first-line treatment in HER2+ metastatic colorectal cancer—Trial in progress.

PDF

Tanios Bekaii-Saab, MD discusses "MOUNTAINEER-03: Phase 3 study of tucatinib, trastuzumab, and mFOLFOX6 as first-line treatment in HER2+ metastatic colorectal cancer—Trial in progress." in this virtual poster presentation.

Released: February 01, 2023

Expiration: January 31, 2024